 SEATTLE, Wash. and VANCOUVER, British Columbia, March 08, 2022 GLOBE NEWSWIRE -- Achieve Life Sciences, Inc. NASDAQ: ACHV, a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced it will be participating in the Oppenheimer 32nd Annual Virtual Healthcare Conference and the Maxim 2022 Virtual Growth Conference. 